Search for the latest oncology news by tumour type
MYC targeting by omomyc synergizes with PARP inhibition and potentiates antitumour response in preclinical models of triple-negative breast cancer
Findings from a preclinical study led by VHIO’s Models of Cancer Therapies Group, directed by…